Eledon Pharmaceuticals Inc logo

Eledon Pharmaceuticals Inc

$ 2.66 -0.09 (-3.27%) 10:08 PM EST
P/E:
At Loss
P/B:
0.23
Market Cap:
$ 36.59M
Enterprise V:
$ -32.04M
Volume:
14.09K
Avg Vol (2M):
19.86K
Also Trade In:
Volume:
14.09K
Market Cap $:
36.59M
PE Ratio:
At Loss
Avg Vol (2-Month):
19.86K
Enterprise Value $:
-32.04M
PB Ratio:
0.23
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's lead compound in development is AT-1501 which is the next generation anti-CD40L antibody.
Name Current Vs Industry Vs History
Cash-To-Debt 120.24
Equity-to-Asset 0.97
Debt-to-EBITDA -0.02
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 11.41
9-Day RSI 20.35
14-Day RSI 29.09
6-1 Month Momentum % -0.79
12-1 Month Momentum % -34.26

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 22.22
Quick Ratio 22.22
Cash Ratio 21.51

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -201.2

Financials (Next Earnings Date:2022-11-11 Est.)

ELDN's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ELDN

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -2.6
Beta 1.15
Volatility % 61.29
14-Day RSI 29.09
14-Day ATR ($) 0.243033
20-Day SMA ($) 3.1375
12-1 Month Momentum % -34.26
52-Week Range ($) 2.27 - 6.21
Shares Outstanding (Mil) 13.76

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Eledon Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Eledon Pharmaceuticals Inc Analysis

Share your research

Headlines

See More
No news.